An Open Receptor-Binding Cavity of Hemagglutinin-Esterase-Fusion Glycoprotein from Newly-Identified Influenza D Virus: Basis for Its Broad Cell Tropism.
An Open Receptor-Binding Cavity of Hemagglutinin-Esterase-Fusion Glycoprotein from Newly-Identified Influenza D Virus: Basis for Its Broad Cell Tropism.
复制标题
DOI:
10.1371/journal.ppat.1005411
复制
发表时间:
2016-01
期刊:
影响因子:
6.7
通讯作者:
Gao GF
中科院分区:
文献类型:
--
作者:
Song H;Qi J;Khedri Z;Diaz S;Yu H;Chen X;Varki A;Shi Y;Gao GF
Influenza viruses cause seasonal flu each year and pandemics or epidemic sporadically, posing a major threat to public health. Recently, a new influenza D virus (IDV) was isolated from pigs and cattle. Here, we reveal that the IDV utilizes 9-O-acetylated sialic acids as its receptor for virus entry. Then, we determined the crystal structures of hemagglutinin-esterase-fusion glycoprotein (HEF) of IDV both in its free form and in complex with the receptor and enzymatic substrate analogs. The IDV HEF shows an extremely similar structural fold as the human-infecting influenza C virus (ICV) HEF. However, IDV HEF has an open receptor-binding cavity to accommodate diverse extended glycan moieties. This structural difference provides an explanation for the phenomenon that the IDV has a broad cell tropism. As IDV HEF is structurally and functionally similar to ICV HEF, our findings highlight the potential threat of the virus to public health. Of the Orthomyxoviridae family of viruses, influenza A, B and C viruses all can cause disease in humans. Recently, a novel influenza D virus (IDV) with approximately 50% amino acid identity to human influenza C virus (ICV) is found in pigs and cattle. This novel virus can establish infection in other mammals including ferrets and guinea pigs. However, the cellular receptor for viral entry and the molecular mechanism for its broad host range is unclear. We performed combined structural and functional studies on the viral surface protein, hemagglutinin-esterase-fusion (HEF), and demonstrated that IDV (like ICV) uses 9-O-acetylated sialic acid as its receptor, but the IDV HEF has an open receptor-binding cavity to accommodate diverse extended glycan moieties. Our findings reveal in exquisite detail how the receptors or substrates bind to the receptor-binding site or esterase active site, providing a clue for the development of novel therapeutics against the conserved esterase pocket. Furthermore, the IDV HEF can bind human trachea epithelia, indicating that the IDV virus may become a potential threat to public health.